Tecserena to be Fonar distributor:
This article was originally published in Clinica
Fonar, the Melville, New York-based developer of magnetic resonance imaging (MRI) systems, has appointed Cologne, Germany-based Tecserena as its new European representative and distributor. Tecserena, which was established as a dedicated sales outlet for Fonar's MRI systems, is managed by three former employees of Hitachi Medical Systems: Matthias Schulz, Alfred Schlemmer and Holger Frey. The company has already begun marketing throughout Europe the Fonar Upright MRI system, the US firm's latest reclining scanner, the Fonar 360, and its "work-in-progress" operating room MRI.
You may also be interested in...
Attorneys say Sarepta did not have an obligation to report its appeal, particularly since winning a formal dispute filing with the US FDA is a long shot.
Sarepta’s Vyondys: Renal Toxicity Concerns That Delayed Approval Get Enhanced Postmarketing Scrutiny, Label Warning
Sarepta must perform enhanced pharmacovigilance for serious renal toxicity events and rhabdomyolysis with the Duchenne muscular dystrophy drug, which carries a label warning for renal toxicity. Approval letter includes 2024 target completion date for ESSENCE confirmatory trial.
Efficacy data were striking to committee members, but they want to ensure postmarketing plans gather adequate data to address safety questions.